fbpx

#phase 3 randomized Archway trial

Implant Reduces Treatment Burden in Wet Macular Degeneration

by: Laird Harrison A ranibizumab implant (Port Delivery System) could ease treatment burden, and even improve long-term visual acuity, in people with neovascular age-related macular degeneration, interim results from the phase 3 randomized Archway…

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.